Razan Alolyani/X
Sep 6, 2026, 18:11
Razan Alolyani: Our Research on Anticoagulation After Acute Ischemic Stroke Receives 2nd Place
Razan Alolyani, Senior PharmD Student at King Saud bin Abdulaziz University for Health Sciences, College of Pharmacy, shared a post on X:
“I am honored to share that our research, ‘Early vs. Delayed Anticoagulation After Acute Ischemic Stroke in Atrial Fibrillation,’ received 2nd place at SSCP 2026.
Truly grateful to Lama Alfehaid for her invaluable guidance, support, and mentorship throughout this journey.”
Stay updated with Hemostasis Today.
-
Oct 16, 2026, 16:01Obi Light Ogbonnia: The Greatest Reward Is Changing Lives, Not Winning Awards
-
Oct 16, 2026, 15:18Carmine Liberatore: Limited Accuracy of VTE Risk Scores in Multiple Myeloma
-
Oct 16, 2026, 14:55Alex Borstein and the Bleeding Phenotype of Hemophilia A Carriers
-
Oct 16, 2026, 13:59Aya Akmal Amin: Antiphospholipid Syndrome Management and Risk Stratification
-
Oct 16, 2026, 13:10Emanuel Sueldo: CAHT 2026 Celebrates Scientific Progress and Team Achievements
-
Oct 16, 2026, 13:05Maha Othman: Queen’s Health Sciences Advances CAT Risk Models and Pediatric ISTH-BAT Cut-Offs
-
Oct 16, 2026, 13:03Thrombosis Awareness Must Lead to Timely Action – Roche
-
Oct 16, 2026, 12:49Wolfgang Miesbach: 5-Year CBDR Data Confirms Emicizumab Safety and Efficacy in Hemophilia A
-
Oct 16, 2026, 12:40Edward Lee Carter: How Factor XI Inhibition Could Transform Anticoagulation Therapy